These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35140170)

  • 1. IQOS marketing strategies at point-of-sales: a cross-sectional survey with retailers.
    Bar-Zeev Y; Berg CJ; Khayat A; Romm KF; Wysota CN; Abroms LC; Elbaz D; Levine H
    Tob Control; 2023 Aug; 32(e2):e198-e204. PubMed ID: 35140170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IQOS point-of-sale marketing: a comparison between Arab and Jewish neighborhoods in Israel.
    Khayat A; Levine H; Berg CJ; Abroms LC; Duan Z; Wang Y; LoParco CR; Elbaz D; Cui Y; Bar-Zeev Y
    Res Sq; 2024 Mar; ():. PubMed ID: 38464035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IQOS point-of-sale marketing strategies in Israel: a pilot study.
    Bar-Zeev Y; Levine H; Rubinstein G; Khateb I; Berg CJ
    Isr J Health Policy Res; 2019 Jan; 8(1):11. PubMed ID: 30642383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of IQOS Marketing Strategies at Points-of-Sale in Israel at a Time of Regulatory Transition.
    Bar-Zeev Y; Berg CJ; Abroms LC; Rodnay M; Elbaz D; Khayat A; Levine H
    Nicotine Tob Res; 2022 Jan; 24(1):100-108. PubMed ID: 34216461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IQOS point-of-sale marketing: a comparison between Arab and Jewish neighborhoods in Israel.
    Khayat A; Levine H; Berg CJ; Abroms LC; Duan Z; Wang Y; LoParco CR; Elbaz D; Cui Y; Bar-Zeev Y
    Isr J Health Policy Res; 2024 Aug; 13(1):39. PubMed ID: 39152466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low compliance and proliferation of IQOS purchase cues at points-of-sale: a comparative study before and after Israel's display ban.
    Bar-Zeev Y; Berg CJ; Khayat A; Abroms LC; Wang Y; Duan Z; LoParco CR; Cui Y; Elbaz D; Levine H
    Tob Control; 2024 Jun; ():. PubMed ID: 38862232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PMI's IQOS and cigarette ads in Israeli media: a content analysis across regulatory periods and target population subgroups.
    Khayat A; Berg CJ; Levine H; Rodnay M; Abroms L; Romm KF; Duan Z; Bar-Zeev Y
    Tob Control; 2024 Mar; 33(e1):e54-e61. PubMed ID: 36418166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brief report on IQOS point-of-sale marketing, promotion and pricing in IQOS retail partner stores in Atlanta, Georgia, USA.
    Henderson KC; Van Do V; Wang Y; Duan Z; Popova L; Spears CA; Weaver SR; Ashley DL; Barker DC; Huang J
    Tob Control; 2023 Aug; 32(e2):e260-e264. PubMed ID: 35918133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Point-of-sale marketing of heated tobacco products in Israel: cause for concern.
    Halpern-Felsher B
    Isr J Health Policy Res; 2019 May; 8(1):47. PubMed ID: 31133053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IQOS: examination of Philip Morris International's claim of reduced exposure.
    St Helen G; Jacob Iii P; Nardone N; Benowitz NL
    Tob Control; 2018 Nov; 27(Suppl 1):s30-s36. PubMed ID: 30158205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Industry marketing of tobacco products on social media: case study of Philip Morris International's IQOS.
    Abroms LC; Wysota CN; Tosakoon S; Khayat A; Duan Z; Bar-Zeev Y; Berg CJ; Levine H
    Tob Control; 2024 Jun; 33(4):518-524. PubMed ID: 36927516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDA's reduced exposure marketing order for IQOS: why it is not a reliable global model.
    Lempert LK; Bialous S; Glantz S
    Tob Control; 2022 Aug; 31(e1):e83-e87. PubMed ID: 33811155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marketing IQOS in a dark market.
    Mathers A; Schwartz R; O'Connor S; Fung M; Diemert L
    Tob Control; 2019 Mar; 28(2):237-238. PubMed ID: 29724866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heated tobacco products likely appeal to adolescents and young adults.
    McKelvey K; Popova L; Kim M; Chaffee BW; Vijayaraghavan M; Ling P; Halpern-Felsher B
    Tob Control; 2018 Nov; 27(Suppl 1):s41-s47. PubMed ID: 30352843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determining the impact of smoking point of sale legislation among youth (Display) study: a protocol for an evaluation of public health policy.
    Haw S; Amos A; Eadie D; Frank J; MacDonald L; MacKintosh AM; MacGregor A; Miller M; Pearce J; Sharp C; Stead M; Tisch C; van der Sluijs W
    BMC Public Health; 2014 Mar; 14():251. PubMed ID: 24628879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "It Looks Like an Adult Sweetie Shop": Point-of-Sale Tobacco Display Exposure and Brand Awareness in Scottish Secondary School Students.
    van der Sluijs W; Haseen F; Miller M; MacGregor A; Sharp C; Amos A; Best C; Stead M; Eadie D; Pearce J; Frank J; Haw S
    Nicotine Tob Res; 2016 Oct; 18(10):1981-1988. PubMed ID: 26883750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Point-of-Sale Tobacco Advertising and Display Bans: Policy Evaluation Study in Five Russian Cities.
    Kennedy RD; Grant A; Spires M; Cohen JE
    JMIR Public Health Surveill; 2017 Aug; 3(3):e52. PubMed ID: 28811269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tobacco and E-Cigarettes Point of Sale Advertising-Assessing Compliance with Tobacco Advertising, Promotion and Sponsorship Bans in Poland.
    Polanska K; Kaleta D
    Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33670741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'The last line of marketing': Covert tobacco marketing tactics as revealed by former tobacco industry employees.
    Watts C; Burton S; Freeman B
    Glob Public Health; 2021 Jul; 16(7):1000-1013. PubMed ID: 32946326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of IQOS introduction on Philip Morris International cigarette sales in Spain: a Logarithmic Mean Divisa Index decomposition approach.
    Golpe AA; Martín-Álvarez JM; Galiano A; Asensio E
    Gac Sanit; 2022; 36(4):293-300. PubMed ID: 35219532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.